Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy

NCT05270759 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.

NCT NCT05270759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05270759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Phase
Observational
Overall status
Completed
Start date
March 1, 2022
Completion date
September 17, 2024
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, chronic kidney disease stage 5 on dialysis, chronic kidney failure, fluid overload, intradialytic hypotension